메뉴 건너뛰기




Volumn 44, Issue 10, 2004, Pages 1106-1113

Could the WHO Model List of Essential Medicines do more for the safe and appropriate use of injections?

Author keywords

Injectable medicines; Injection devices; Injection safety; Rational use; WHO Model List of Essential Medicines

Indexed keywords

ANALGESIC AGENT; ANESTHETIC AGENT; ANTIALLERGIC AGENT; ANTICONVULSIVE AGENT; ANTIDOTE; ANTIINFECTIVE AGENT; ANTIMIGRAINE AGENT; ANTINEOPLASTIC AGENT; ANTIPARKINSON AGENT; ANTIPYRETIC AGENT; ANTIRHEUMATIC AGENT; CARDIOVASCULAR AGENT; CHOLINESTERASE INHIBITOR; CONTRACEPTIVE AGENT; DERMATOLOGICAL AGENT; DIAGNOSTIC AGENT; DISINFECTANT AGENT; DIURETIC AGENT; ESSENTIAL DRUG; GASTROINTESTINAL AGENT; HORMONE; IMMUNOLOGIC AGENT; IMMUNOSUPPRESSIVE AGENT; MINERAL; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OXYTOCIC AGENT; PSYCHOTROPIC AGENT; UNINDEXED DRUG; VITAMIN;

EID: 4444269289     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270004268410     Document Type: Article
Times cited : (4)

References (36)
  • 1
    • 0242574305 scopus 로고    scopus 로고
    • Use of injections in health care setting worldwide, 2000: Literature review and regional estimates
    • Hutin YJ, Hauri AM, Armstrong GL. Use of injections in health care setting worldwide, 2000: literature review and regional estimates. Br Med J. 2003;327:1075.
    • (2003) Br Med J , vol.327 , pp. 1075
    • Hutin, Y.J.1    Hauri, A.M.2    Armstrong, G.L.3
  • 3
    • 0038409777 scopus 로고
    • Intervención para mejorar la calidad de prescripción de antibióticos en una area básica de salud
    • Casado Zuriguel I. Intervención para mejorar la calidad de prescripción de antibióticos en una area básica de salud. Atencion Primaria. 1993;11:53-55.
    • (1993) Atencion Primaria , vol.11 , pp. 53-55
    • Casado Zuriguel, I.1
  • 4
    • 0017168223 scopus 로고
    • Effect of medical care review on the use of injections
    • Brook RH, Williams KN. Effect of medical care review on the use of injections. Ann Intern Med. 1976;85:509-515.
    • (1976) Ann Intern Med , vol.85 , pp. 509-515
    • Brook, R.H.1    Williams, K.N.2
  • 5
    • 0032726232 scopus 로고    scopus 로고
    • Unsafe injections in the developing world and transmission of blood-borne pathogens
    • Simonsen L, Kane A, Lloyd J, Zaffran M, Kane M. Unsafe injections in the developing world and transmission of blood-borne pathogens. Bull World Health Organ. 1999;77:789-800.
    • (1999) Bull World Health Organ , vol.77 , pp. 789-800
    • Simonsen, L.1    Kane, A.2    Lloyd, J.3    Zaffran, M.4    Kane, M.5
  • 6
    • 0347302936 scopus 로고    scopus 로고
    • The global burden of disease attributable to contaminated injections given in health care settings
    • Hauri A, Armstrong G, Hutin Y. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15:7-16.
    • (2004) Int J STD AIDS , vol.15 , pp. 7-16
    • Hauri, A.1    Armstrong, G.2    Hutin, Y.3
  • 7
    • 0032743717 scopus 로고    scopus 로고
    • Transmission of hepatitis B, hepatitis C and HIV through unsafe injection in the developing world: Model-based regional estimates
    • Kane A, et al. Lloyd J, Zaffran M, Simonsen L, Kane M. Transmission of hepatitis B, hepatitis C and HIV through unsafe injection in the developing world: model-based regional estimates. Bull World Health Organ. 1999;77:801-807.
    • (1999) Bull World Health Organ , vol.77 , pp. 801-807
    • Kane, A.1    Lloyd, J.2    Zaffran, M.3    Simonsen, L.4    Kane, M.5
  • 10
    • 0033501110 scopus 로고    scopus 로고
    • WHO model list of essential drugs (Revised December 1999)
    • World Health Organization. WHO Model List of Essential Drugs (revised December 1999). WHO Drug Info. 1999;13:249-262. Retrieved from: www.who.int/medicines/organization/par/edl/eml.shtml
    • (1999) WHO Drug Info , vol.13 , pp. 249-262
  • 13
    • 4444293037 scopus 로고    scopus 로고
    • Boston: MSH
    • Management Sciences for Health (MSH), Center for Pharmaceutical Management. International Drug Price Indicator Guide. Boston: MSH, 2000. Retrieved from: www.msh.org
    • (2000) International Drug Price Indicator Guide
  • 14
    • 4444301358 scopus 로고    scopus 로고
    • November (amended) (restricted access with password)
    • United Nations Children's Funds. Essential drugs indicative price list, November 1999 (amended). Retrieved from: www.supply.unicef.dk/catalogue/index. htm (restricted access with password)
    • (1999) Essential Drugs Indicative Price List
  • 15
    • 0009775092 scopus 로고    scopus 로고
    • May (restricted access with password)
    • International Dispensation Association. Price indicator, May 2001. Retrieved from: www.ida.nl/en-us/content.aspx?cid=42 (restricted access with password)
    • (2001) Price Indicator
  • 16
    • 0041846495 scopus 로고    scopus 로고
    • Best infection control practices for intradermal, subcutaneous and intramuscular needle injections
    • Hutin Y, Hauri A, Chiarello L, et al. Best infection control practices for intradermal, subcutaneous and intramuscular needle injections. Bull World Health Organ. 2003;81:491-500.
    • (2003) Bull World Health Organ , vol.81 , pp. 491-500
    • Hutin, Y.1    Hauri, A.2    Chiarello, L.3
  • 17
    • 0029058515 scopus 로고
    • Patenteral versus oral antibiotic therapy
    • Craig WA, Andes DR. Patenteral versus oral antibiotic therapy. Med Clin North Am. 1995;79:497-508.
    • (1995) Med Clin North Am , vol.79 , pp. 497-508
    • Craig, W.A.1    Andes, D.R.2
  • 19
    • 0024505503 scopus 로고
    • Impact of an essential drugs programme on availability and rational use of drugs
    • Hogerzeil HV, Walker GJ, Sallami AO, Fernando G. Impact of an essential drugs programme on availability and rational use of drugs. Lancet. 1989;8630:41-42.
    • (1989) Lancet , vol.8630 , pp. 41-42
    • Hogerzeil, H.V.1    Walker, G.J.2    Sallami, A.O.3    Fernando, G.4
  • 22
    • 0011792340 scopus 로고    scopus 로고
    • WHO document WHO/EPI/LHIS/97.04REV.1. Retrieved from: whqlibdoc.who.int/hq/2002/WHO_V&B_02.10.pdf
    • World Health Organization. WHO-UNICEF policy statement for mass immunization campaigns, 1997. WHO document WHO/EPI/LHIS/97.04REV.1. Retrieved from: whqlibdoc.who.int/hq/2002/WHO_V&B_02.10.pdf
    • (1997) WHO-UNICEF Policy Statement for Mass Immunization Campaigns
  • 30
    • 0003731910 scopus 로고    scopus 로고
    • Reducing risks, promoting healthy life: Some strategies to reduce risk
    • Geneva, Switzerland: World Health Organization
    • World Health Organization. Reducing risks, promoting healthy life: some strategies to reduce risk. In: World Health Report, 2002. Geneva, Switzerland: World Health Organization, 2002;101-144.
    • (2002) World Health Report, 2002 , pp. 101-144
  • 33
    • 4444328851 scopus 로고    scopus 로고
    • WHO document WHO/HIV/2002.16
    • World Health Organization. Leading the health sector response to HIV/AIDS, 2002 WHO document WHO/HIV/2002.16. Retrieved from: www.who.int/hiv/pub/advocacy/pubxx/en/
    • (2002) Leading the Health Sector Response to HIV/AIDS
  • 34
    • 4444317434 scopus 로고    scopus 로고
    • WHO document WHO/BCT/03.04
    • World Health Organization. Procuring single-use injection equipment and safety boxes, 2003. WHO document WHO/BCT/03.04. Retrieved from: www.who.int/injection_safety/toolbox/docs/en/Procurement.pdf1
    • (2003) Procuring Single-Use Injection Equipment and Safety Boxes
  • 35
    • 4444363768 scopus 로고    scopus 로고
    • WHO document WHO/BCT/02.11
    • World Health Organization. Injection practices: rapid assessment and response guide, 2002. WHO document WHO/BCT/02.11. Retrieved from: www.who.int/injection_safety/toolbox/en/RARG.pdf
    • (2002) Injection Practices: Rapid Assessment and Response Guide
  • 36
    • 0008499886 scopus 로고    scopus 로고
    • WHO document WHO/V&B/01.30
    • World Health Organization. Tool for the assessment of injection safety, 2001. WHO document WHO/V&B/01.30. Retrieved from: www.who.int/ injection_safety/toolbox/en/InjectionSafetyAssessmentTool.pdf
    • (2001) Tool for the Assessment of Injection Safety


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.